triazoles has been researched along with E coli Infections in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Afifi, TH; Ahmed, HEA; Alswah, M; Bayoumi, AH; El-Gamal, KM; El-Morsy, A; Ghiaty, A; Mansour, BA; Mohammed, AS; Omar, AM; Sherbiny, FF | 1 |
| Chan, EWC; Chan, KF; Chan, TH; Chen, S; Cheung, Q; Gao, W; Jin, WB; Leung, YC; Liu, J; Wong, KY; Xu, C; Zeng, P | 1 |
| Pajpani, M; Webb, R | 1 |
| Gou, C; Li, C; Li, XZ; Li, YR; Liu, HY; Liu, JC; Piao, HR; Zhang, ML; Zheng, CJ | 1 |
| Dong, F; Guo, Z; Li, Q; Liu, Y; Tan, W; Wang, H; Zhang, J | 1 |
| Badr, SM; Barwa, RM | 1 |
| Folkesson, HG; Kuzenko, SR; Lipson, DA; Matthay, MA; Simmons, MA | 1 |
| Harada, AS; Lau, W | 1 |
| Qin, X; Yu, P; Yuan, J | 1 |
| Bar-Natan, MF; Garrison, RN; Spain, DA; Wilson, MA | 1 |
| Kim, KH; Park, KW; Yim, CB | 1 |
| Hirata, Y; Kato, M; Matsuzaki, M; Nakumura, K; Tado, N | 1 |
| Bennett, IS; Brooks, G; Broom, NJ; Calvert, SH; Coleman, K; François, I | 1 |
13 other study(ies) available for triazoles and E coli Infections
| Article | Year |
|---|---|
Antimicrobial screening and pharmacokinetic profiling of novel phenyl-[1,2,4]triazolo[4,3-a]quinoxaline analogues targeting DHFR and E. coli DNA gyrase B.
Topics: Anti-Bacterial Agents; DNA Gyrase; Escherichia coli; Escherichia coli Infections; Folic Acid Antagonists; Humans; Models, Molecular; Quinoxalines; Structure-Activity Relationship; Tetrahydrofolate Dehydrogenase; Topoisomerase II Inhibitors; Triazoles | 2020 |
Bioisosteric investigation of ebselen: Synthesis and in vitro characterization of 1,2-benzisothiazol-3(2H)-one derivatives as potent New Delhi metallo-β-lactamase inhibitors.
Topics: Anti-Bacterial Agents; Azoles; beta-Lactamase Inhibitors; beta-Lactamases; Escherichia coli; Escherichia coli Infections; Escherichia coli Proteins; Humans; Isoindoles; Molecular Docking Simulation; Organoselenium Compounds; Triazoles | 2020 |
Lingual necrosis caused by mucormycosis in a patient with aplastic anaemia: case report.
Topics: Aged, 80 and over; Amphotericin B; Anemia, Aplastic; Antifungal Agents; Escherichia coli Infections; Fatal Outcome; Female; Humans; Immunocompromised Host; Mucormycosis; Necrosis; Rhizopus; Tongue; Triazoles | 2014 |
Synthesis and antimicrobial evaluation of 5-aryl-1,2,4-triazole-3-thione derivatives containing a rhodanine moiety.
Topics: Anti-Infective Agents; Candida albicans; Candidiasis; Escherichia coli; Escherichia coli Infections; Humans; Rhodanine; Staphylococcal Infections; Staphylococcus aureus; Thiones; Triazoles | 2015 |
Synthesis, characterization, and antibacterial property of novel starch derivatives with 1,2,3-triazole.
Topics: Anti-Bacterial Agents; Click Chemistry; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Starch; Triazoles | 2016 |
Synthesis of some new [1,2,4]triazolo[3,4-b][1,3,4]thiadiazines and [1,2,4]triazolo[3,4-b][1,3,4] thiadiazoles starting from 5-nitro-2-furoic acid and evaluation of their antimicrobial activity.
Topics: Anti-Bacterial Agents; Cell Survival; Escherichia coli; Escherichia coli Infections; HCT116 Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Thiadiazines; Thiadiazoles; Triazoles | 2011 |
The adenosine 2A receptor agonist GW328267C improves lung function after acute lung injury in rats.
Topics: Acute Lung Injury; Adenosine; Amiloride; Animals; Biological Transport; Bronchoalveolar Lavage; Cystic Fibrosis Transmembrane Conductance Regulator; Endotoxemia; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Escherichia coli; Escherichia coli Infections; Immunoblotting; Male; Pneumonia; Pulmonary Alveoli; Pulmonary Edema; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Respiratory Physiological Phenomena; Sodium Channel Blockers; Triazoles | 2012 |
Successful treatment and limb salvage of mucor necrotizing fasciitis after kidney transplantation with posaconazole.
Topics: Alcaligenes; Amphotericin B; Amputation, Surgical; Antifungal Agents; Cefazolin; Combined Modality Therapy; Debridement; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Combinations; Drug Resistance, Multiple, Fungal; Escherichia coli Infections; Fatal Outcome; Fluconazole; Gangrene; Graft Rejection; Gram-Negative Bacterial Infections; Humans; Immunocompromised Host; Immunosuppressive Agents; Kidney Transplantation; Leg; Leg Ulcer; Male; Middle Aged; Mucor; Mucormycosis; Penicillanic Acid; Phosphatidylcholines; Phosphatidylglycerols; Piperacillin; Postoperative Complications; Pyrimidines; Renal Dialysis; Reoperation; Sepsis; Skin Transplantation; Tazobactam; Triazoles; Voriconazole | 2007 |
[The effect of platelet-activating factor antagonists on early bacteria translocation of rat after burn injury].
Topics: Animals; Azepines; Bacterial Translocation; Burns; Escherichia coli; Escherichia coli Infections; Platelet Activating Factor; Random Allocation; Rats; Rats, Wistar; Triazoles | 1995 |
Platelet-activating factor and sepsis-induced small intestinal microvascular hypoperfusion.
Topics: Animals; Azepines; Bacteremia; Escherichia coli Infections; Intestine, Small; Male; Microcirculation; Platelet Activating Factor; Rats; Rats, Sprague-Dawley; Triazoles; Vasoconstriction | 1995 |
Comparative activities of novel beta-lactamase inhibitors, 6-exomethylene penamsulfones (CH1240, CH2140) in experimental mouse infection model.
Topics: Animals; Anti-Bacterial Agents; Bacterial Infections; beta-Lactamase Inhibitors; Citrobacter; Clavulanic Acid; Enterobacteriaceae Infections; Enzyme Inhibitors; Escherichia coli Infections; Lethal Dose 50; Male; Mice; Mice, Inbred ICR; Penicillanic Acid; Pseudomonas Infections; Sulbactam; Triazoles | 1998 |
[Bacteriological studies on cefatrizine (S-640 P) (author's transl)].
Topics: Animals; Cephalexin; Cephalosporins; Drug Evaluation, Preclinical; Escherichia coli; Escherichia coli Infections; Klebsiella; Klebsiella Infections; Mice; Microbial Sensitivity Tests; Protein Binding; Proteus Infections; Salmonella; Shigella; Species Specificity; Staphylococcal Infections; Streptococcal Infections; Streptococcus; Streptococcus pneumoniae; Streptococcus pyogenes; Triazoles | 1976 |
6-(substituted methylene)penems, potent broad spectrum inhibitors of bacterial beta-lactamase. V. Chiral 1,2,3-triazolyl derivatives.
Topics: Amoxicillin; Animals; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Drug Synergism; Escherichia coli Infections; Humans; Mice; Microbial Sensitivity Tests; Structure-Activity Relationship; Triazoles | 1991 |